Remyelination varies between and within lesions in multiple sclerosis following bexarotene

J. William L. Brown; Ferran Prados; Daniel R. Altmann; Baris Kanber; Jonathan Stutters; Nick G. Cunniffe; Joanne L. Jones; Zoya G. Georgieva; Edward J. Needham; Cyrus Daruwalla; Claudia Gandini Wheeler‐kingshott; Peter Connick; Siddharthan Chandran; Robin Franklin; David Macmanus; Rebecca Samson; Alasdair Coles; Declan Chard

doi:10.1002/acn3.51662

Remyelination varies between and within lesions in multiple sclerosis following bexarotene

J. William L. Brown, Ferran Prados, Daniel R. Altmann, Baris Kanber, Jonathan Stutters, Nick G. Cunniffe, Joanne L. Jones, Zoya G. Georgieva, Edward J. Needham, Cyrus Daruwalla, Claudia Gandini Wheeler‐kingshott, Peter Connick, Siddharthan Chandran, Robin Franklin, David Macmanus, Rebecca Samson, Alasdair Coles, Declan Chard

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Annals of Clinical and Translational Neurology
Early online date	17 Sept 2022
DOIs	https://doi.org/10.1002/acn3.51662
Publication status	E-pub ahead of print - 17 Sept 2022

Access to Document

10.1002/acn3.51662

Ann Clin Transl Neurol - 2022 - Brown - Remyelination varies between and within lesions in multiple sclerosis followingFinal published version, 557 KBLicence: Creative Commons: Attribution (CC-BY)

https://onlinelibrary.wiley.com/doi/10.1002/acn3.51662

Cite this

Brown, J. W. L., Prados, F., Altmann, D. R., Kanber, B., Stutters, J., Cunniffe, N. G., Jones, J. L., Georgieva, Z. G., Needham, E. J., Daruwalla, C., Wheeler‐kingshott, C. G., Connick, P., Chandran, S., Franklin, R., Macmanus, D., Samson, R., Coles, A., & Chard, D. (2022). Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Annals of Clinical and Translational Neurology. Advance online publication. https://doi.org/10.1002/acn3.51662

@article{3cefe381f8034a37b09110dea0b8cd0e,

title = "Remyelination varies between and within lesions in multiple sclerosis following bexarotene",

author = "Brown, {J. William L.} and Ferran Prados and Altmann, {Daniel R.} and Baris Kanber and Jonathan Stutters and Cunniffe, {Nick G.} and Jones, {Joanne L.} and Georgieva, {Zoya G.} and Needham, {Edward J.} and Cyrus Daruwalla and Wheeler‐kingshott, {Claudia Gandini} and Peter Connick and Siddharthan Chandran and Robin Franklin and David Macmanus and Rebecca Samson and Alasdair Coles and Declan Chard",

note = "Funding Information: JWLB is an NIHR advanced fellow. NGC and JWLB were supported by the Thorne Family Foundation and the Grand Charity of the Freemasons. NGC is supported by the MS Society of the United Kingdom. FP, BK, and DTC are supported by the NIHR UCLH Biomedical Research Centre at UCL and UCLH. The Cambridge MS trial team is supported by the NIHR Cambridge Biomedical Research Centre (BRC‐1215‐20014). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. CAMGW‐K receives funds from the MS Society of the United Kingdom (#77), Wings for Life (#169111), Horizon2020 (CDS‐QUAMRI, #634541), and The Biomedical Research Council (#BRC704/CAP/CGW). This research was also funded in part, by the Wellcome Trust (Grant number RG79413 to support JLJ and RG92001 to support ZGG.). For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. RJMF acknowledges support from the Adeslon Medical Research Foundation. Funding Information: This work was funded by the MS Society of the United Kingdom. Publisher Copyright: {\textcopyright} 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.",

year = "2022",

month = sep,

day = "17",

doi = "10.1002/acn3.51662",

language = "English",

journal = "Annals of Clinical and Translational Neurology",

issn = "2328-9503",

publisher = "Wiley",

}

Brown, JWL, Prados, F, Altmann, DR, Kanber, B, Stutters, J, Cunniffe, NG, Jones, JL, Georgieva, ZG, Needham, EJ, Daruwalla, C, Wheeler‐kingshott, CG, Connick, P , Chandran, S, Franklin, R, Macmanus, D, Samson, R, Coles, A & Chard, D 2022, 'Remyelination varies between and within lesions in multiple sclerosis following bexarotene', Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51662

TY - JOUR

T1 - Remyelination varies between and within lesions in multiple sclerosis following bexarotene

AU - Brown, J. William L.

AU - Prados, Ferran

AU - Altmann, Daniel R.

AU - Kanber, Baris

AU - Stutters, Jonathan

AU - Cunniffe, Nick G.

AU - Jones, Joanne L.

AU - Georgieva, Zoya G.

AU - Needham, Edward J.

AU - Daruwalla, Cyrus

AU - Wheeler‐kingshott, Claudia Gandini

AU - Connick, Peter

AU - Chandran, Siddharthan

AU - Franklin, Robin

AU - Macmanus, David

AU - Samson, Rebecca

AU - Coles, Alasdair

AU - Chard, Declan

N1 - Funding Information: JWLB is an NIHR advanced fellow. NGC and JWLB were supported by the Thorne Family Foundation and the Grand Charity of the Freemasons. NGC is supported by the MS Society of the United Kingdom. FP, BK, and DTC are supported by the NIHR UCLH Biomedical Research Centre at UCL and UCLH. The Cambridge MS trial team is supported by the NIHR Cambridge Biomedical Research Centre (BRC‐1215‐20014). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. CAMGW‐K receives funds from the MS Society of the United Kingdom (#77), Wings for Life (#169111), Horizon2020 (CDS‐QUAMRI, #634541), and The Biomedical Research Council (#BRC704/CAP/CGW). This research was also funded in part, by the Wellcome Trust (Grant number RG79413 to support JLJ and RG92001 to support ZGG.). For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. RJMF acknowledges support from the Adeslon Medical Research Foundation. Funding Information: This work was funded by the MS Society of the United Kingdom. Publisher Copyright: © 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

PY - 2022/9/17

Y1 - 2022/9/17

U2 - 10.1002/acn3.51662

DO - 10.1002/acn3.51662

M3 - Article

SN - 2328-9503

JO - Annals of Clinical and Translational Neurology

JF - Annals of Clinical and Translational Neurology

ER -